Excision BioTherapeutics

Excision BioTherapeutics is a clinical-stage biotechnology company developing CRISPR-based gene-editing therapies intended to functionally cure serious viral infectious diseases. Its programs use multiplexed CRISPR/Cas approaches delivered via adeno-associated virus (AAV) to excise latent viral DNA from infected cells, with a lead candidate (EBT-101) targeting HIV and additional research directed at herpesviruses and hepatitis B. The company was surfaced as a portfolio company of Battery Ventures and added to the API Evangelist network. As a therapeutics company it does not currently publish a public developer API, SDK, or documentation surface; this profile therefore carries company identity and domain-security posture rather than API artifacts.

Excision BioTherapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Gene Editing, CRISPR, and Therapeutics.

🌐 Visit website 📡 Source on GitHub
3.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyBiotechnologyGene EditingCRISPRTherapeuticsInfectious DiseaseLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 3.3/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 1.1 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/excision-biotherapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Excision Biotherapeutics Domain Security

no transport/DNS hardening detected

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: excision-biotherapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/excision-biotherapeutics.png
name: Excision BioTherapeutics
description: Excision BioTherapeutics is a clinical-stage biotechnology company developing CRISPR-based gene-editing therapies
  intended to functionally cure serious viral infectious diseases. Its programs use multiplexed CRISPR/Cas approaches delivered
  via adeno-associated virus (AAV) to excise latent viral DNA from infected cells, with a lead candidate (EBT-101) targeting
  HIV and additional research directed at herpesviruses and hepatitis B. The company was surfaced as a portfolio company of
  Battery Ventures and added to the API Evangelist network. As a therapeutics company it does not currently publish a public
  developer API, SDK, or documentation surface; this profile therefore carries company identity and domain-security posture
  rather than API artifacts.
url: https://raw.githubusercontent.com/api-evangelist/excision-biotherapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- battery-ventures
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Gene Editing
- CRISPR
- Therapeutics
- Infectious Disease
- Life Sciences
apis: []
common:
- type: DomainSecurity
  url: security/excision-biotherapeutics-domain-security.yml
- type: Website
  url: https://www.excision.bio
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence